Sundaram Preethi

Sundaram Preethi is listed in filings as Chief Strategy Officer at Catalyst Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Dec 30, 2025, including sale activity. Recent filings connect the profile to Catalyst Pharmaceuticals, Inc. (CPRX). The current snapshot covers public activity from Nov 25, 2024 to Dec 30, 2025. Reported amounts are shown as $2.4M to $61.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.